Hypotensive and vasorelaxant effects of the procyanidin fraction from Guazuma ulmifolia bark in normotensive and hypertensive rats.
OBJECTIVE
was to investigate the in vivo and in vitro cardiovascular activity of a procyanidin fraction (PCF) obtained from acetone extract of Guazuma ulmifolia bark which has traditionally been used as an antihypertensive agent.


RESULTS
10 mg/kg PCF doses orally administered to sugar-fed hypertensive rats decreased both the systolic arterial pressure and the heart rate, whereas the same doses intravenously administered induced arterial hypotension which was attenuated by NG-nitro-L-arginine methylester (L-NAME 31 mg/kg) pretreatment. In these experiments we employed carbachol as a positive control test. The PCF reduced the contraction induced by norepinephrine (1x10(-7) M) in isolated aortic rings of normotensive (IC50=35.3+/-12.4 ng/mL) and sugar-fed hypertensive (IC50=101.3+/-57.2 ng/mL) rats. This relaxant activity was inhibited by either vascular endothelium removal or L-NAME (30 microM) pretreatment, while indomethacin (10 microM) or atropine (10 microM) had no effect. Preliminary analysis of the PCF by HPLC-DAD-MS and FAB+ mass spectrometry allowed the detection of the main components such as the complex of procyanidin oligomers consisting mainly of tetramers and trimers.


CONCLUSIONS
Guazuma ulmifolia bark possesses long-lasting antihypertensive and vasorelaxing properties linked to the endothelium related factors, where nitric oxide is involved.
Magos
Gil Alfonso
GA
Departamento de Farmacología, Facultad de Medicina, Universidad Nacional Autónoma de México, Apartado Postal No. 70-297, 04510 México, D.F., Mexico. gamagos@servidor.unam.mx
Mateos
Juan Carlos
JC
Páez
Elna
E
Fernández
Gabriela
G
Lobato
Carlos
C
Márquez
Carmen
C
Enríquez
Raúl Guillermo
RG
D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects / Q000502:physiology; D044946:Biflavonoids / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects*; D002392:Catechin / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D019660:Malvaceae / Q000737:chemistry*; D009569:Nitric Oxide / Q000096:biosynthesis; D010936:Plant Extracts / Q000494:pharmacology*; D010946:Plants, Medicinal / Q000737:chemistry*; D044945:Proanthocyanidins / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D044140:Receptor, Angiotensin, Type 1 / Q000502:physiology; D014664:Vasodilation / Q000187:drug effects*
D044946:Biflavonoids; D010936:Plant Extracts; D044945:Proanthocyanidins; D044140:Receptor, Angiotensin, Type 1; D009569:Nitric Oxide; C017674:procyanidin; D002392:Catechin